Rax is responsible for identifying new and innovative drug discovery candidates, the maturation of active projects, and Medipure’s relationships with current and future drug discovery partners. He is a key resource in evaluating early-stage projects and is responsible for the medicinal chemistry and pre-clinical strategies and projects. In addition to his current role in Drug Discovery R&D, he is also leading Medipure’s QA/QC and Regulatory Affairs departments to ensure that developed pharmaceutical products comply with all applicable regulatory standards.
Rax brings 15 years of R&D experience to the Medipure team in the areas of drug discovery, medicinal chemistry, biochemistry, pharmacology and overall project risk assessment. He has held several R&D positions in the industry and successfully managed multiple projects in lead generation and lead optimization resulting in the advancement of proprietary drugs into clinical trials. He received his Ph.D. from University of Hohenheim in Germany with specializations in Biochemistry and Toxicology. He has co-authored 25 peer-reviewed scientific publications and is listed as a co-inventor on 3 filed patents.